Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Expert Opinion on Biological Therapy|March 3, 2020
Current and emerging biologics for the treatment of juvenile idiopathic arthritisRolando Cimaz, Gabriella Maioli, Giulia CalabreseExpert Opinion on Drug Discovery|June 27, 2022
Lessons learned from the preclinical discovery and development of sarilumab for the treatment of rheumatoid arthritisGabriella Maioli, Roberto Caporali, Ennio Giulio FavalliDrugs|July 1, 2024
Biologics or Janus Kinase Inhibitors in Rheumatoid Arthritis Patients Who are Insufficient Responders to Conventional Anti-Rheumatic DrugsEnnio Giulio Favalli, Gabriella Maioli, Roberto CaporaliExpert Review of Clinical Immunology|March 31, 2021
Clinical management of patients with rheumatoid arthritis during the COVID-19 pandemicEnnio Giulio Favalli, Gabriella Maioli, Martina Biggioggero, et al.Clinical and Experimental Rheumatology|June 10, 2024
The change over time in the prescription pattern of the first targeted drug after failure of conventional therapy in patients with rheumatoid arthritis: a 20-year real-world experienceGabriella Maioli, Gilberto Cincinelli, Martina Biggioggero, et al.Arthritis Research & Therapy|September 17, 2024
Truth unveiled by time and the marbled definition of D2T-RA: retrospective analysis on the persistence of the difficult-to-treat status among refractory RA patientsGilberto Cincinelli, Gabriella Maioli, Cristina Posio, et al.Seminars in Respiratory and Critical Care Medicine|May 29, 2019
Lung Disease in Antiphospholipid SyndromeGabriella Maioli, Giulia Calabrese, Franco Capsoni, et al.Frontiers in Immunology|September 18, 2023
The impact of EMA recommendations on the real-life use of Janus kinases inhibitors for rheumatoid arthritis: the Expanded Risk Score in RA as a tool to quantify the risk of cardiovascular eventsEnnio Giulio Favalli, Gilberto Cincinelli, Sabino Germinario, et al.ACR Open Rheumatology|May 19, 2025
Whole-Blood RNA Sequencing Profiling of Patients With Rheumatoid Arthritis Treated With TofacitinibChiara Bellocchi, Ennio Giulio Favalli, Gabriella Maioli, et al.Frontiers in Medicine|April 1, 2022
The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM StudyEnnio Giulio Favalli, Andrea Gobbini, Mauro Bombaci, et al.Pageof 2